Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · IEX Real-Time Price · USD
4.240
-0.030 (-0.70%)
Mar 28, 2024, 11:47 AM EDT - Market open

Century Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Cash & Equivalents
49.386.2458.1627.73
Short-Term Investments
125.41231.23166.4348.54
Cash & Cash Equivalents
174.72317.48224.676.27
Cash Growth
-44.97%41.35%194.47%-
Other Current Assets
2.282.243.562.53
Total Current Assets
176.99319.72228.1578.8
Property, Plant & Equipment
92.08111.7369.8224.78
Long-Term Investments
89.151.85135.911.05
Other Long-Term Assets
2.523.243.492.15
Total Long-Term Assets
183.7166.82209.2227.98
Total Assets
360.69486.54437.38106.78
Accounts Payable
2.745.457.68.08
Deferred Revenue
115.75117.9900
Current Debt
06.51.040
Other Current Liabilities
-100.65-100.137.024.03
Total Current Liabilities
17.8529.8215.6612.11
Long-Term Debt
46.6642.4423.4621.32
Other Long-Term Liabilities
111.44111.552.020
Total Long-Term Liabilities
158.1153.9925.4821.32
Total Liabilities
175.94183.8141.1433.43
Total Debt
46.6648.9424.521.32
Debt Growth
-4.66%99.74%14.95%-
Retained Earnings
-655.77-519.1-388.17-292.34
Comprehensive Income
0.11-2.46-0.65-0
Shareholders' Equity
184.75302.74396.24-106.41
Net Cash / Debt
128.06268.54200.154.96
Net Cash / Debt Growth
-52.31%34.21%264.11%-
Net Cash Per Share
2.164.656.187.35
Working Capital
159.15289.9212.566.69
Book Value Per Share
3.125.2412.23-14.22
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).